PROPERTY, PLANT AND EQUIPMENT

12 Months Ended

Apr. 01, 2023

Property, Plant and Equipment [Abstract]

Property, plant and equipment consisted of the following:


(In thousands)	April 1, 2023		April 2, 2022
Land	$	5,358	$	5,165
Building and building improvements	127,634		104,363
Plant equipment and machinery	194,539		180,140
Office equipment and information technology	123,611		120,119
Haemonetics equipment	463,706		405,753
Construction in progress	29,367		53,607
Total	944,215		869,147
Less: accumulated depreciation	(633,330)		(610,665)
Property, plant and equipment, net	$	310,885	$	258,482

Depreciation expense was $51.2 million, $44.4 million and $43.1 million in fiscal 2023, 2022 and 2021, respectively.

During fiscal 2022, the Company incurred an impairment of property, plant and equipment of $5.2 million in connection with the 2020 Program, refer to Note 3 - Restructuring for details on the 2020 Program, and $2.8 million of accelerated depreciation costs related to disposables manufacturing equipment that was no longer in use. In fiscal 2021, the Company incurred a one-time impairment charge of $20.9 million related to in-process disposables manufacturing equipment that would not be placed in service. These impairment charges were included in cost of goods sold on the consolidated statements of income and impacted the Plasma reporting segment in the respective periods.